Katrin Schwarze
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Katrin Schwarze has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Daniel Patschan
Department of Internal Medicine I - Cardiology, Nephrology and Internal Intensive Care Medicine, University Hospital Brandenburg, Brandenburg Medical School (Theodor Fontane), Hochstraße 29, 14770, Brandenburg an der Havel, Germany.
1 shared publication - Elvira Henze
Clinic of Nephrology and Rheumatology, University Hospital of Göttingen, Robert-Koch-Straße 40, 37075, Göttingen, Germany
1 shared publication - Gerhard Anton Müller
Georg-August-Universitat Gottingen Universitatsmedizin
1 shared publication - Jörg Rinneburger
Department of Nephrology and Rheumatology, University Hospital of Göttingen, Robert-Koch-Straße 40, 37077 Göttingen, Germany
1 shared publication - Nazif Idrizi
Department of Nephrology and Rheumatology, University Hospital of Göttingen, Robert-Koch-Straße 40, 37077 Göttingen, Germany
1 shared publication - Rico Backhaus
Department of Nephrology and Rheumatology, University Hospital of Göttingen, Robert-Koch-Straße 40, 37077 Göttingen, Germany
1 shared publication
Latest Publications
- Open Access
- 21 October 2013
- Published by Springer Nature in BMC Nephrology
- Vol. 14 (1) , 227
Angiopoietin-1 treated early endothelial outgrowth cells (eEOCs) are activated in vitro and reduce renal damage in murine acute ischemic kidney injury (iAKI)
Acute kidney injury (AKI) severely worsens prognosis of hospitalized patients. Early Endothelial Outgrowth Cells act protective in murine acute ischemic renal failure and renoprotective actions of eEOCs have been documented to increase after cell pretreatment with 8-O-cAMP and Melatonin. Angiopoietin-1 is critically involved in maintaining vascular integrity and regeneration. Aim of the study was to analyze the consequences of eEOC treatment with Ang-1 in murine AKI.
- 21 October 2013
- Published by Springer Nature in BMC Nephrology
- Vol. 14 (1) , 227
Open AccessAngiopoietin-1 treated early endothelial outgrowth cells (eEOCs) are activated in vitro and reduce renal damage in murine acute ischemic kidney injury (iAKI)
Acute kidney injury (AKI) severely worsens prognosis of hospitalized patients. Early Endothelial Outgrowth Cells act protective in murine acute ischemic renal failure and renoprotective actions of eEOCs have been documented to increase after cell pretreatment with 8-O-cAMP and Melatonin. Angiopoietin-1 is critically involved in maintaining vascular integrity and regeneration. Aim of the study was to analyze the consequences of eEOC treatment with Ang-1 in murine AKI.